AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Segmental Vibrator With NMES on Lower Limb Function in Subacute Stroke

RecruitingNAAges 45 Years - 60 YearsAllRiphah International University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Stroke is one of the world's leading causes of death and disability. It can cause a variety of motor disorders, such as apraxia, sensory deficits, abnormal muscle tone, inadequate weight transfer, lack of fine motor skills, incoordination, and balance deficit. These disorders can have a significant negative impact on a person's quality of life.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Both male and female patients were included in the study. * The age range of participants was between 45 and 60 years. * Participants that were diagnosed with ischemic stroke patient. * Participants had experienced sub-acute ischemic stroke, specifically 15 days to 12 weeks post-stroke. * Montreal Cognitive Assessment scores falling within the range of 18-24 were necessary. * Modified Ashworth scale scores had to be less than +1 * National Institutes of Health Stroke Scale (NIHSS) score falling within the range of 1 to 15 were necessary. * Participants feel no pain from the vibrator. * It was anticipated that participants would either be able to give informed consent or have a legal representative who could do so. Exclusion Criteria: * People who had a history of serious neurological or mental conditions that would have impeded lower limb motor recovery-aside from stroke-were not included. * Individuals with severe arthritis or joint injuries, among other illnesses that would have interfered with treatment or evaluations, were not allowed to participate. * Individuals who had significant hearing or vision impairments that would have hampered treatment or evaluations were not included. * Individuals undergoing anti-spatial therapy or other clinical trials, those with bilateral brain lesions, and those with ischemic involvement of the cerebellum or basal ganglia were not allowed to participate. * Participants having metal implants e. g cardiac pacemaker and skin lesion at the site of stimulation electrodes were excluded.
๐Ÿ’Š

What it tests

  • Experimental Group A: Segmental vibrator only on dorsiflexor
  • Experimental Group B: Segmental vibrator + Electrical stimulation on dorsiflexors
๐Ÿ“

Where

1 site
Jinnah Hospital
Lahore, Pakistan
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy